Founder and Managing Partner
Capita3Check size: Not publicly specified on the official site
At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.
Capita3's published criteria emphasize breakthrough deep technology and health companies with evidence, strong teams, and a credible path to product-market fit. This is firm-level context, not an unsupported personal attribution.
No person-specific exclusions were published. At the firm level, opportunities without a deep-technology or healthcare fit and evidence-backed differentiation are unlikely to fit.
Use Capita3's official contact or application channel. Lead with fit to Pre-seed, Seed, and Series A, explain why the company matches Deep technology, digital health, and healthcare, and support claims with traction and a concise use-of-capital plan.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Sara Russick is listed by Capita3 on its current official team roster as Founder and Managing Partner. No additional personal claims are made without an official source.